BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2158.56 only $755.50

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
US Tech 100
20,266.40
0.33%
Dow Jones
44,296.51
0.97%
Brent Oil
74.65
0.00%
Bitcoin
98,527.69
0.76%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. Resverlogix Corp (RVX) Quote

Resverlogix Corp

Resverlogix Corp (RVX)

TSX
0.06
0.005
(9.09%)
Closed November 23 4:12PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.06
Bid
0.055
Ask
0.06
Volume
28,306
0.055 Day's Range 0.06
0.04 52 Week Range 0.095
Market Cap
16.342M
Previous Close
0.055
Open
0.055
Last Trade
25000
@
0.06
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
81,057
Shares Outstanding
272,371,000
Dividend Yield
-
PE Ratio
-0.98
Earnings Per Share (EPS)
-0.06
Revenue
57k
Net Profit
-16.74M

About Resverlogix Corp

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.resverlogix.com
Headquarters
Calgary, Alberta, Can
Founded
-
Resverlogix Corp is listed in the Biological Pds,ex Diagnstics sector of the Toronto Stock Exchange with ticker RVX. The last closing price for Resverlogix was $0.06. Over the last year, Resverlogix shares have traded in a share price range of $ 0.04 to $ 0.095.

Resverlogix currently has 272,371,000 shares outstanding. The market capitalization of Resverlogix is $14.98 million. Resverlogix has a price to earnings ratio (PE ratio) of -0.98.

Ask ADVFN Intelligence (AI)

RVX Latest News

More News

InvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditions

VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (TSX:RVX) (OTCPink:RVXCF), a world leader in epigenetics, or gene regulation, announced that apabetalone’s...

September 30 2022
GlobeNewswire Inc.

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) today announced that apabetalone’s future clinical development related to...

September 28 2022
GlobeNewswire Inc.

Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Reduction in the Risk of Major Adverse...

August 22 2022
GlobeNewswire Inc.

Resverlogix Announces Appointment of New Chief Scientific Officer

CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the appointment of Dr. Ewelina Kulikowski, Ph.D. as Chief Scientific Officer. Dr...

August 15 2022
GlobeNewswire Inc.

Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders

CALGARY, Alberta, June 21, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today held its Annual Meeting of Shareholders (the “Meeting”) in Calgary...

June 21 2022
GlobeNewswire Inc.

Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors

CALGARY, Alberta, June 08, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Breaking boundaries: Pan BETi disrupt 3D...

June 08 2022
GlobeNewswire Inc.

Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

CALGARY, Alberta, May 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix", or "the Company") (TSX:RVX), in partnership with EVERSANA™, today announced that the U.S. Food and Drug...

May 09 2022
GlobeNewswire Inc.

Resverlogix Announces One-Year Extension of Debenture

CALGARY, Alberta, April 19, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) announced today that it has closed a one-year extension of Company’s US$6.0...

April 19 2022
GlobeNewswire Inc.

Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “BET Protein Inhibition for Pulmonary...

March 17 2022
GlobeNewswire Inc.

Resverlogix Corp. to Webcast Live at VirtualInvestorConferences.com March 10th

CALGARY, Alberta, March 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX), a global leader in the development of epigenetic therapeutics, today announced that Donald...

March 09 2022
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.060.060.055622950.05509632CS
4-0.005-7.692307692310.0650.0650.055446750.06047601CS
12-0.03-33.33333333330.090.090.045810570.06657742CS
260.0059.090909090910.0550.0950.04667500.06868008CS
52-0.01-14.28571428570.070.0950.04554870.06676398CS
156-0.39-86.66666666670.450.820.04668630.18860569CS
260-1.13-94.95798319331.191.590.04651650.47484997CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AABAberdeen International Inc
$ 0.065
(18.18%)
226.54k
MDPMedexus Pharmaceuticals Inc
$ 2.45
(15.02%)
46.31k
NCFNorthcliff Resources Ltd
$ 0.04
(14.29%)
5k
SAMStarcore International Mines Ltd
$ 0.16
(14.29%)
200k
GECGlobal Education Communities Corp
$ 0.225
(12.50%)
60k
BNGBengal Energy Ltd
$ 0.005
(-50.00%)
20k
RTGRTG Mining Inc
$ 0.03
(-25.00%)
13k
SMCSulliden Mining Capital Inc
$ 0.015
(-25.00%)
200k
APSAptose Biosciences Inc
$ 0.27
(-20.59%)
346.55k
FLNTFlint Corporation
$ 0.025
(-16.67%)
28k
SUSuncor Energy Inc
$ 58.04
(0.94%)
14.14M
MFCManulife Financial Corporation
$ 45.42
(-0.53%)
9.73M
SLFSun Life Financial Inc
$ 85.54
(-0.23%)
6.19M
BITFBitfarms Ltd
$ 2.96
(3.14%)
6.17M
CNQCanadian Natural Resources Ltd
$ 48.70
(0.83%)
4.91M

RVX Discussion

View Posts
alvaroc2 alvaroc2 8 years ago
TA breaking 2,50 try 3 $.
👍️0
alvaroc2 alvaroc2 8 years ago
No analist cover at the moment, when news came.....
👍️0
alvaroc2 alvaroc2 8 years ago
Good evening clase 2,41 near high 2,47,good news and many conferences in march and april.
👍️0

Your Recent History

TSX
RVX
Resverlogix
DOWI
A1ENE
DJ Americas Oil & Gas
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Ultimate Trader

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years $3395.52 only $1358.21